There's new evidence that connects testing positive for COVID-19 antibodies from a prior infection with a significantly lower risk of becoming infected again in the future. A study, published in the ...

Rogue antibodies may be to blame for some of long COVID’s pernicious symptoms. Two new studies suggest that antibodies that attack people’s own tissues might cause ongoing neurological issues that ...

Though the peak of COVID-19 deaths is thankfully behind us, the virus is still a pernicious public health threat that vexes drugmakers by constantly evolving new variants that can elude existing ...

The updated NCCN Guidelines now include the recommendation for monoclonal antibodies for pre-exposure prophylaxis against COVID-19, highlighting the significance of Invivyd's products in cancer care.

In the ongoing battle against COVID-19, the United States has leaned heavily on vaccines as its primary weapon. While vaccination has been a cornerstone of the country’s public health strategy, it's ...

As access to COVID-19 vaccines dwindles in the US, one company seems to be positioning its products as an alternative way of preventing the disease. Invivyd is the manufacturer of pemivibart, a ...

UVA Health researchers have discovered a potential explanation for some of the most perplexing mysteries of COVID-19 and long COVID. The surprising findings could lead to new treatments for the ...

Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. New research suggests that the casirivimab-imdevimab monoclonal antibody treatment for COVID-19 ...

Some people are worried that another Covid surge is coming, powered by omicron's highly contagious BA.2 subvariant. But experts say a significant jump in cases is unlikely, at least for now — possibly ...

We're keeping an eye on new influenza and SARS-CoV-2 viral variants. Here's what we know about those viruses—and your immune ...

Many people who oppose taking Covid-19 vaccines have cited concerns over the risks of using new technology to deal with a disease. But many of them are flocking to hospitals after having contracted ...